Overview
Yoshikawa holds a Ph.D. in Molecular Biology from The University of Tokyo [10] and a Master of Life Science in Biochemistry and Molecular Biology from Kyoto University [12]. Yoshikawa serves as a Venture Partner at ARCH Venture Partners [1][4], a position held since May 2025 [4], following a tenure as Senior Advisor at the same firm from May 2023 to May 2025 [5]. Yoshikawa has held concurrent roles as President and General Manager, Japan at Typewriter Therapeutics, Inc., beginning in January 2023 [2][3]. Earlier career experience includes service as Executive Officer at Beyond Next Ventures from 2018 to 2022 [7], Chief Strategy Officer at A-SEEDS Co., Ltd. [6], and co-founding of the Uhuru project, an educational nonprofit [9].
Career history
- President, JapanApr 2026 to presentTypewriter Therapeutics, Inc.
- General Manager, JapanJan 2023 to presentTypewriter Therapeutics, Inc.
- Venture PartnerMay 2025 to presentARCH Venture Partners
- Senior AdvisorMay 2023 to May 2025ARCH Venture Partners
- Chief Strategy Officer (CSO)Jul 2023 to Mar 2026A-SEEDS Co., Ltd.
- Executive OfficerJan 2018 to Sep 2022Beyond Next Ventures (VC)
- ManagerOct 2016 to Jan 2018Beyond Next Ventures (VC)
- Co-founderAug 2014 to Dec 2018Uhuru project, class for everyone (NPO)
Education
- Ph.D., Molecular BiologyJan 2011 - Jan 2014The University of Tokyo
- Global Health Leadership Program (GHLP), Global Health2011 - 2011The University of Tokyo
- Master of Life Science, Biochemistry and Molecular Biology2009 - 2011Kyoto University
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.